Yakob Liawatidewi - 15 Mar 2025 Form 4 Insider Report for Amphastar Pharmaceuticals, Inc. (AMPH)

Role
EVP CORP ADMIN CENTER, Director
Signature
/s/ Eva Wen, by power of attorney
Issuer symbol
AMPH
Transactions as of
15 Mar 2025
Net transactions value
-$75,418
Form type
4
Filing time
18 Mar 2025, 18:41:24 UTC
Previous filing
12 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMPH Common Stock Tax liability $27,486 -1,031 -1.1% $26.66 92,640 15 Mar 2025 Direct F1
transaction AMPH Common Stock Tax liability $47,931 -1,731 -1.9% $27.69 90,909 17 Mar 2025 Direct F1
holding AMPH Common Stock 2,459 15 Mar 2025 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs.
F2 The reported shares are held of record by the Yakob and Sunmoon Trust dated July 25, 2013 for which the reporting person serves as a trustee.